PRESS RELEASESFlagship Pioneering's Scientists Invent A New Category Of Genome Engineering Technology: Gene WritingBy PR NewswireJul 7, 2020 8:00 AM EDT
PRESS RELEASESAxcella Announces Patent Issuances Covering AXA1665By Business WireJun 17, 2020 8:00 AM EDT
PRESS RELEASESAxcella To Present At Goldman Sachs 41st Annual Global Healthcare ConferenceBy Business WireJun 3, 2020 8:00 AM EDT
PRESS RELEASESAxcella Announces Closing Of Public Offering Of Common Stock, Including Full Exercise Of Underwriters' OptionBy Business WireMay 18, 2020 4:05 PM EDT
PRESS RELEASESAxcella Announces Pricing Of Public Offering Of Common StockBy Business WireMay 13, 2020 10:31 PM EDT
PRESS RELEASESAxcella To Report Top-Line Data From AXA1125-003 In Adult Subjects With NAFLD On May 6, 2020By Business WireMay 5, 2020 4:05 PM EDT
PRESS RELEASESAxcella To Hold Virtual-Only 2020 Annual Meeting Of StockholdersBy Business WireMay 4, 2020 4:05 PM EDT
PRESS RELEASESAxcella Receives Fourth Patent Covering EMM CompositionsBy Business WireApr 7, 2020 8:00 AM EDT
PRESS RELEASESAxcella Completes Enrollment Of Subjects In AXA1665-002 StudyBy Business WireFeb 26, 2020 7:30 AM EST
PRESS RELEASESAxcella To Present At The SVB Leerink 9th Annual Global Healthcare ConferenceBy Business WireFeb 19, 2020 8:00 AM EST
PRESS RELEASESAxcella To Present At J.P. Morgan Healthcare ConferenceBy Business WireJan 9, 2020 8:00 AM EST
PRESS RELEASESAxcella Announces Positive Interim Findings From Ongoing Clinical Study Of AXA1125/AXA1957 In Subjects With NAFLD And Expected 2020 MilestonesBy Business WireJan 8, 2020 8:00 AM EST
